DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Varespladib
Varespladib
Effects of Varespladib Methyl on Biomarkers and Major Cardiovascular Events in Acute Coronary Syndrome Patients
Phospholipase A2 Regulates Eicosanoid Class Switching During Inflammasome Activation
A Novel JAK1 Mutant Breast Implant-Associated Anaplastic Large Cell Lymphoma Patient-Derived Xenograft Fostering Pre- Clinical Discoveries
Customs Tariff - Schedule
CUSTOMS TARIFF - SCHEDULE 99 - I
Stembook 2018.Pdf
(Spla2-IIA) Inhibitors in Inflammatory Ocular Disease Treatment
(12) United States Patent (10) Patent No.: US 9,572,800 B2 Zarnitsyn Et Al
Known Bioactive Library: Selleck Bioactive 10Mm, 3.33Mm, 1.11Mm
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Current Awareness in Clinical Toxicology Editors: Damian Ballam Msc and Allister Vale MD
NIH Public Access Author Manuscript Chem Rev
Varespladib and Cardiovascular Events in Patients with an Acute Coronary Syndrome the VISTA-16 Randomized Clinical Trial
(Nsaids): Progress in Small Molecule Drug Development
Visual Barcodes for Multiplexing Live Microscopy-Based Assays
Inflammation in Cardiovascular Disease: from Basic Concepts to Clinical Application David D
(12) Patent Application Publication (10) Pub. No.: US 2010/0226943 A1 Brennan Et Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Top View
Vaso-Occlusion in Sickle Cell Anemia
(12) Patent Application Publication (10) Pub. No.: US 2017/0056347 A1 Glick Et Al
Structural and Functional Aspects of Targeting the Secreted Human Group IIA Phospholipase A2
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
UC San Francisco Previously Published Works
AS TARGET ENZYMES for NEW ANTI-INFLAMMATORY DRUGS: a Theoretical and Experimental Study